HepG2 cells expressing MicroRNA miR-122 support the entire hepatitis C virus life cycle

Journal of Virology

Volumn 85, Issue 22, 2011, Pages 12087-12092

  Narbus, Christopher M ^a   Israelow, Benjamin ^a   Sourisseau, Marion ^a   Michta, Maria L ^a   Hopcraft, Sharon E ^a   Zeiner, Gusti M ^b   Evans, Matthew J ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GREEN FLUORESCENT PROTEIN; MICRORNA; RNA POLYMERASE II; VIRUS RNA;

ANIMAL CELL; CELL CULTURE; CELL STRAIN HEPG2; CONTROLLED STUDY; FLAVIVIRUS; GENE REPLICATION; HEPATITIS C VIRUS; IN VIVO STUDY; LIFE CYCLE; NONHUMAN; NOTE; PRIORITY JOURNAL; REPLICON; RNA REPLICATION; RNA STABILITY; VIRION; VIRUS ENTRY; VIRUS REPLICATION;

GENE EXPRESSION; HEP G2 CELLS; HEPACIVIRUS; HEPATOCYTES; HUMANS; MICRORNAS; VIRUS INTERNALIZATION; VIRUS RELEASE; VIRUS REPLICATION;

HEPATITIS C VIRUS;

EID: 80655142481     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.05843-11     Document Type: Note

References (42)

1. Alter, M. J., et al. 1999. The prevalence of hepatitis C virus infection in the United States, 1988 through 1994. N. Engl. J. Med. 341:556-562.
2. Ambros, V. 2004. The functions of animal microRNAs. Nature 431:350-355.
3. Bartel, D. P. 2004. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116:281-297.
4. Bartosch, B., et al. 2003. Cell entry of hepatitis C virus requires a set of co-receptors that include the CD81 tetraspanin and the SR-B1 scavenger receptor. J. Biol. Chem. 278:41624-41630.
5. Blight, K. J., A. A. Kolykhalov, and C. M. Rice. 2000. Efficient initiation of HCV RNA replication in cell culture. Science 290:1972-1974.
6. Blight, K. J., J. A. McKeating, and C. M. Rice. 2002. Highly permissive cell lines for hepatitis C virus genomic and subgenomic RNA replication. J. Virol. 76:13001-13014.
7. Brown, Jr., R. S. 2005. Hepatitis C and liver transplantation. Nature 436: 973-978.
8. Chang, J., et al. 2008. Liver-specific microRNA miR-122 enhances the replication of hepatitis C virus in nonhepatic cells. J. Virol. 82:8215-8223.
9. Coller, K. E., et al. 2009. RNA interference and single particle tracking analysis of hepatitis C virus endocytosis. PLoS Pathog. 5:e1000702.
10. Decaens, C., M. Durand, B. Grosse, and D. Cassio. 2008. Which in vitro models could be best used to study hepatocyte polarity? Biol. Cell 100:387-398.
11. Evans, M. J., et al. 2007. Claudin-1 is a hepatitis C virus co-receptor required for a late step in entry. Nature 446:801-805.
12. Flint, M., et al. 2006. Diverse CD81 proteins support hepatitis C virus infection. J. Virol. 80:11331-11342.
13. Gastaminza, P., et al. 2010. Ultrastructural and biophysical characterization of hepatitis C virus particles produced in cell culture. J. Virol. 84:10999-11009.
14. Haid, S., M. P. Windisch, R. Bartenschlager, and T. Pietschmann. 2010. Mouse-specific residues of claudin-1 limit hepatitis C virus genotype 2a infection in a human hepatocyte cell line. J. Virol. 84:964-975.
15. Harris, H. J., et al. 2010. Claudin association with CD81 defines hepatitis C virus entry. J. Biol. Chem. 285:21092-21102.
16. Henke, J. I., et al. 2008. microRNA-122 stimulates translation of hepatitis C virus RNA. EMBO J. 27:3300-3310.
17. Jangra, R. K., M. Yi, and S. M. Lemon. 2010. Regulation of hepatitis C virus translation and infectious virus production by the microRNA miR-122. J. Virol. 84:6615-6625.
18. Jopling, C. L., S. Schutz, and P. Sarnow. 2008. Position-dependent function for a tandem microRNA miR-122-binding site located in the hepatitis C virus RNA genome. Cell Host Microbe 4:77-85.
19. Jopling, C. L., M. Yi, A. M. Lancaster, S. M. Lemon, and P. Sarnow. 2005. Modulation of hepatitis C virus RNA abundance by a liver-specific microRNA. Science 309:1577-1581.
20. Kato, T., et al. 2003. Efficient replication of the genotype 2a hepatitis C virus subgenomic replicon. Gastroenterology 125:1808-1817.
21. Lanford, R. E., et al. 2010. Therapeutic silencing of microRNA-122 in primates with chronic hepatitis C virus infection. Science 327:198-201.
22. Lin, L. T., et al. 2010. Replication of subgenomic hepatitis C virus replicons in mouse fibroblasts is facilitated by deletion of interferon regulatory factor 3 and expression of liver-specific microRNA 122. J. Virol. 84:9170-9180.
23. Lindenbach, B. D., et al. 2005. Complete replication of hepatitis C virus in cell culture. Science 309:623-626.
24. Lindenbach, B. D., et al. 2006. Cell culture-grown hepatitis C virus is infectious in vivo and can be recultured in vitro. Proc. Natl. Acad. Sci. U. S. A. 103:3805-3809.
25. Liu, S., et al. 2009. Tight junction proteins claudin-1 and occludin control hepatitis C virus entry and are downregulated during infection to prevent superinfection. J. Virol. 83:2011-2014.
26. Machlin, E. S., P. Sarnow, and S. M. Sagan. 2011. Masking the 5' terminal nucleotides of the hepatitis C virus genome by an unconventional microRNA-target RNA complex. Proc. Natl. Acad. Sci. U. S. A. 108:3193-3198.
27. Mee, C. J., et al. 2010. Hepatitis C virus infection reduces hepatocellular polarity in a vascular endothelial growth factor-dependent manner. Gastroenterology 138:1134-1142.
28. Mee, C. J., et al. 2009. Polarization restricts hepatitis C virus entry into HepG2 hepatoma cells. J. Virol. 83:6211-6221.
29. Merz, A., et al. 2011. Biochemical and morphological properties of hepatitis C virus particles and determination of their lipidome. J. Biol. Chem. 286: 3018-3032.
30. Michta, M. L., et al. 2010. Species-specific regions of occludin required by hepatitis C virus for cell entry. J. Virol. 84:11696-11708.
31. Montalto, G., et al. 2002. Epidemiology, risk factors, and natural history of hepatocellular carcinoma. Ann. N. Y. Acad. Sci. 963:13-20.
32. Pall, G. S., and A. J. Hamilton. 2008. Improved northern blot method for enhanced detection of small RNA. Nat. Protoc. 3:1077-1084.
33. Perez, J. T., et al. 2010. Influenza A virus-generated small RNAs regulate the switch from transcription to replication. Proc. Natl. Acad. Sci. U. S. A. 107:11525-11530.
34. Pietschmann, T., et al. 2006. Construction and characterization of infectious intragenotypic and intergenotypic hepatitis C virus chimeras. Proc. Natl. Acad. Sci. U. S. A. 103:7408-7413.
35. Ploss, A., et al. 2009. Human occludin is a hepatitis C virus entry factor required for infection of mouse cells. Nature 457:882-886.
36. Prentoe, J., and J. Bukh. 2011. Hepatitis C virus expressing flag-tagged envelope protein 2 has unaltered infectivity and density, is specifically neutralized by flag antibodies and can be purified by affinity chromatography. Virology 409:148-155.
37. Tannous, B. A., D. E. Kim, J. L. Fernandez, R. Weissleder, and X. O. Breakefield. 2005. Codon-optimized Gaussia luciferase cDNA for mammalian gene expression in culture and in vivo. Mol. Ther. 11:435-443.
38. Verhaegent, M., and T. K. Christopoulos. 2002. Recombinant Gaussia luciferase. Overexpression, purification, and analytical application of a bioluminescent reporter for DNA hybridization. Anal. Chem. 74:4378-4385.
39. Wakita, T., et al. 2005. Production of infectious hepatitis C virus in tissue culture from a cloned viral genome. Nat. Med. 11:791-796.
40. Wilson, J. A., C. Zhang, A. Huys, and C. D. Richardson. 2011. Human Ago2 is required for efficient microRNA 122 regulation of hepatitis C virus RNA accumulation and translation. J. Virol. 85:2342-2350.
41. Zhang, J., et al. 2004. CD81 is required for hepatitis C virus glycoproteinmediated viral infection. J. Virol. 78:1448-1455.
42. Zhong, J., et al. 2005. Robust hepatitis C virus infection in vitro. Proc. Natl. Acad. Sci. U. S. A. 102:9294-9299.